Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK… Grant US-11786529-B2 United States of America 17 Oct 2023
Treatment of B cell cancers using a combination comprising Btk inhibitors Grant US-11701357-B2 United States of America 18 Jul 2023
Anti-PD1 antibodies and their use as therapeutics and diagnostics Grant US-11673951-B2 United States of America 13 Jun 2023
Crystalline forms of (S)-7-(1-(but-2-ynoyl)piperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetr… Grant US-11555038-B2 United States of America 17 Jan 2023
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer Grant US-11534431-B2 United States of America 27 Dec 2022
Anti-PD-L1 antibodies and their use as therapeutics and diagnostics Grant US-11512132-B2 United States of America 29 Nov 2022
Anti-PD1 antibodies and their use as therapeutics and diagnostics Grant US-11186637-B2 United States of America 30 Nov 2021
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer Grant US-10864203-B2 United States of America 15 Dec 2020
Anti-PD-L1 antibodies and their use as therapeutics and diagnostics Grant US-10544225-B2 United States of America 28 Jan 2020
Anti-PD1 antibodies and their use as therapeutics and diagnostics Grant US-10519235-B2 United States of America 31 Dec 2019
Anti-PD1 antibodies and their use as therapeutics and diagnostics Grant US-9988450-B2 United States of America 05 Jun 2018